More Presentations from Dr.Naina Mohamed Pakkir Maideen
Ø Pharmacoeconomics is a branch of health economics which compares the value of one drug to another.
Ø Pharmacoeconomic analysis involves…
¨ Choosing a perspective
¨ Identifying and measuring costs
¨ Identifying and measuring consequences
Ø Common perspectives include:
¨ Patient perspective
¨ Provider perspective
¨ Payer perspective
¨ Society perspective
Ø Healthcare costs are categorised as…
¨ Direct Medical Costs
¨ Direct Nonmedical Costs
¨ Indirect Nonmedical Costs
¨ Intangible Costs
¨ Opportunity Costs
¨ Incremental Costs
Ø Consequences (Outcomes) are categorised as…
¨ Economic outcomes
¨ Clinical outcomes
¨ Humanistic outcomes
¨ Positive outcomes
¨ Negative outcomes
¨ Intermediate outcome
¨ Final outcome
Ø Pharmacoeconomic methodologies include…
¨ Economic evaluations
· Partial economic evaluations
o Cost consequence analysis (CCA) or Cost outcome analysis (COA)
o Cost-of-illness (COI) evaluation
· Full economic evaluations
o Cost Minimization Analysis (CMA)
o Cost Benefit Analysis (CBA)
o Cost Effectiveness Analysis (CEA)
o Cost Utility Analysis (CUA)
¨ Humanistic evaluation
· Health Regulated Quality of Life (HRQOL)
· Patient preferences
· Patient satisfaction
Ø Pharmacoeconomic analysis helps to achieve maximum benefit in limited cost.
Ø Pharmacoeconomic data can be a powerful tool to support various clinical decisions, including effective formulary management, individual patient treatment, medication policy, and resource allocation.
Ø By understanding the principles, methods, and application of pharmacoeconomics, healthcare professionals will be prepared to make better, more-informed decisions regarding the use of pharmaceutical products and services.
